Protalix BioTherapeutics, Inc.
AMEX:PLXBiotechnology
Healthcare
$3.02 +4.21%
+$0.09 today
- Market cap
- $254.64M
- Beta
- 0.01
- P/E (TTM)
- 11.0
- EPS (TTM)
- $0.19
52W Low $1.32High $3.19
Volume 0.96M
Average 0.81M
Price history
Protalix BioTherapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+70.62%
Period high
$3.15
Period low
$1.67
Latest
$3.02
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| SC 13G | Oct 15, 2026 | Oct 15, 2026 | |
| 4 | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 8-K | Aug 12, 2026 | Aug 12, 2026 | |
| 10-Q | Aug 12, 2026 | Aug 12, 2026 | |
| S-8 | Aug 12, 2026 | Aug 12, 2026 |
Competitors
Who does Protalix BioTherapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about PLX's filings, answered from its disclosures.
What is the latest PLX filing?
The latest filing shown is 10-Q dated Nov 10, 2026.
How many recent filings does PLX have?
Intrinsic Alpha currently shows 20 recent filings for PLX.
Continue the stock analysis
Jump to another research area for this company.